ROYAL BANK OF CANADA - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$59,765,000
-21.0%
586,727
-21.8%
0.02%
-20.0%
Q2 2023$75,690,000
+33.9%
750,074
+22.1%
0.02%
+25.0%
Q1 2023$56,530,000
+0.6%
614,464
-0.8%
0.02%0.0%
Q4 2022$56,166,000
+16.2%
619,114
-2.7%
0.02%
+6.7%
Q3 2022$48,354,000
-39.8%
636,167
-33.0%
0.02%
-37.5%
Q2 2022$80,306,000
-9.2%
950,026
-5.8%
0.02%
+9.1%
Q1 2022$88,481,000
+2.5%
1,008,332
+2.2%
0.02%
+10.0%
Q4 2021$86,315,000
-20.7%
986,810
-25.9%
0.02%
-31.0%
Q3 2021$108,885,000
-20.4%
1,331,457
-11.2%
0.03%
-19.4%
Q2 2021$136,730,000
+6.3%
1,498,587
-0.4%
0.04%
-2.7%
Q1 2021$128,617,000
-6.4%
1,504,639
+3.4%
0.04%
-7.5%
Q4 2020$137,410,000
+2.6%
1,455,133
-5.5%
0.04%
-16.7%
Q3 2020$133,866,000
+2.0%
1,539,409
+2.5%
0.05%
-7.7%
Q2 2020$131,212,000
+6.9%
1,502,324
+0.9%
0.05%
-11.9%
Q1 2020$122,752,000
-13.8%
1,488,808
-1.0%
0.06%
+15.7%
Q4 2019$142,405,000
+11.5%
1,503,899
+2.4%
0.05%
+2.0%
Q3 2019$127,679,000
-6.1%
1,469,265
-1.3%
0.05%
-9.1%
Q2 2019$135,914,000
-6.7%
1,488,481
-1.7%
0.06%
-11.3%
Q1 2019$145,619,000
+11.7%
1,514,646
-0.3%
0.06%
-1.6%
Q4 2018$130,332,000
+3.3%
1,518,833
+3.7%
0.06%
+21.2%
Q3 2018$126,213,000
+27.5%
1,464,862
+11.7%
0.05%
+15.6%
Q2 2018$99,025,000
-13.5%
1,310,894
-7.4%
0.04%
-11.8%
Q1 2018$114,439,000
-0.5%
1,415,438
+3.3%
0.05%0.0%
Q4 2017$115,033,000
+1.4%
1,370,096
+3.7%
0.05%
-7.3%
Q3 2017$113,434,000
-5.6%
1,321,315
-8.2%
0.06%
-11.3%
Q2 2017$120,116,000
-1.8%
1,439,031
-12.6%
0.06%
-6.1%
Q1 2017$122,302,000
+11.2%
1,646,718
+9.1%
0.07%
+10.0%
Q4 2016$109,935,000
+15.9%
1,509,274
+25.7%
0.06%
+11.1%
Q3 2016$94,822,000
-0.6%
1,200,874
+3.9%
0.05%
-5.3%
Q2 2016$95,365,000
+23.0%
1,155,783
+8.0%
0.06%
+18.8%
Q1 2016$77,553,000
-13.9%
1,070,573
+2.3%
0.05%
-18.6%
Q4 2015$90,023,000
+62.5%
1,046,310
+73.6%
0.06%
+43.9%
Q3 2015$55,408,000
-14.0%
602,778
-7.9%
0.04%
-8.9%
Q2 2015$64,392,000
-2.7%
654,789
-2.5%
0.04%
-2.2%
Q1 2015$66,203,000
+6.9%
671,351
+0.5%
0.05%
+15.0%
Q4 2014$61,917,000
+0.9%
668,226
+2.6%
0.04%
-4.8%
Q3 2014$61,336,000
+5.8%
651,602
+1.8%
0.04%
+7.7%
Q2 2014$57,967,000
+13.0%
640,320
+6.1%
0.04%
+2.6%
Q1 2014$51,304,000
+15.5%
603,429
+9.2%
0.04%
+18.8%
Q4 2013$44,402,000
+10.1%
552,400
+5.1%
0.03%
+3.2%
Q3 2013$40,337,000
+40.5%
525,817
+29.5%
0.03%
+29.2%
Q2 2013$28,712,000406,0400.02%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders